Mss

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2021-10-05
Clinical Trial Update: Tyrosine Kinase Inhibitor (TKI) + Anti-PD-1 Antibody in TKI-responded Microsatellite Stability/Proficient Mismatch Repair (MSS/pMMR) Metastatic Colorectal Adenocarcinoma. [Phase 2]
Phase 2 trial evaluating a tyrosine kinase inhibitor plus anti-PD-1 antibody in MSS/pMMR metastatic colorectal adenocarcinoma after TKI resp…